Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
JAMA|September 9, 2010
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trialAshraf Coovadia, Elaine J Abrams, Renate Stehlau, et al.The Pediatric Infectious Disease Journal|September 2, 2016
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected ChildrenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.AIDS (London, England)|May 3, 2014
Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxisLouise Kuhn, Gillian Hunt, Karl-Günter Technau, et al.AIDS (London, England)|June 15, 2021
Persistently lower bone mass and bone turnover among South African children living with well controlled HIVYanhan Shen, Stephanie Shiau, Renate Strehlau, et al.The Journal of Pediatrics|July 27, 2020
Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral TherapyStephanie Shiau, Henry Evans, Renate Strehlau, et al.The Pediatric Infectious Disease Journal|January 1, 2014
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysisKarl-Günter Technau, Michael Schomaker, Louise Kuhn, et al.AIDS Care|August 30, 2016
Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV statusPamela M Murnane, Stacy-Lee Sigamoney, Francoise Pinillos, et al.The Lancet. Infectious Diseases|March 20, 2012
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trialLouise Kuhn, Ashraf Coovadia, Renate Strehlau, et al.The Lancet. HIV|November 13, 2018
12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort studyKarl-Günter Technau, Renate Strehlau, Faeezah Patel, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapyAshraf Coovadia, Gillian Hunt, Elaine J Abrams, et al.Pageof 9